Baoqing Wang

Baoqing Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2025 in npj Precision Oncology
Verified
Journal Article
Open access
SWShun Wang
Shun Wang
DHDingtao Hu
Dingtao Hu
RWRuohuang Wang
Ruohuang Wang
JHJie Huang
Jie Huang
BWBaoqing Wang
Baoqing Wang
Lung adenocarcinoma (LUAD) is a major cause of cancer-related mortality globally. Proliferating cells, crucial components of the tumor immune microenvironment (TIME), play a significant role in cancer progression and immunotherapy response. Herein, we utilized multi-omics data and employed a multifaceted approach to delineate the proliferating cell landscape in LUAD. The Scissor algorithm was applied to identify Scissor+ proliferating cell genes associated with prognosis. An integrative machine learning program, comprising 111 algorithms, was developed to construct a Scissor+ proliferating cell risk score (SPRS). The SPRS model demonstrated superior performance in predicting prognosis and clinical outcomes compared to 30 previously published models. The role of SPRS and five pivotal genes in immunotherapy response was evaluated, and their expression was experimentally verified. Multifactorial analysis confirmed SPRS as an independent prognostic factor affecting LUAD patient survival. High- and low-SPRS groups exhibited different biological functions and immune cell infiltration in the TIME. High SPRS patients showed resistance to immunotherapy but increased sensitivity to chemotherapeutic and targeted therapeutic agents. Our study elucidates the dynamics of proliferating cells in LUAD, enhancing prognostic accuracy and highlighting the potential of SPRS and its constituent genes for personalized therapeutic interventions.

5 June 2024 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
SWShun Wang
Shun Wang
RWRuohuang Wang
Ruohuang Wang
DHDingtao Hu
Dingtao Hu
CZCaoxu Zhang
Caoxu Zhang
PCPeng Cao
Peng Cao
BWBaoqing Wang
Baoqing Wang
Ferroptosis, an iron-dependent regulated cell death mechanism, holds significant promise as a therapeutic strategy in oncology. In the current study, we explored the regulatory effects of epigallocatechin gallate (EGCG), a prominent polyphenol in green tea, on ferroptosis and its potential therapeutic implications for non-small cell lung cancer (NSCLC). Treatment of NSCLC cell lines with varying concentrations of EGCG resulted in a notable suppression of cell proliferation, as evidenced by a reduction in Ki67 immunofluorescence staining. Western blot analyses demonstrated that EGCG treatment led to a decrease in the expression of glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11) while increasing the levels of acyl-CoA synthetase long-chain family member 4 (ACSL4). These molecular changes were accompanied by an increase in intracellular iron, malondialdehyde (MDA), and reactive oxygen species (ROS), alongside ultrastructural alterations characteristic of ferroptosis. Through small RNA sequencing and RT-qPCR, transfer RNA-derived small RNA 13502 (tsRNA-13502) was identified as a significant target of EGCG action, with its expression being upregulated in NSCLC tissues compared to adjacent non-tumorous tissues. EGCG was found to modulate the ferroptosis pathway by downregulating tsRNA-13502 and altering the expression of key ferroptosis regulators (GPX4/SLC7A11 and ACSL4), thereby promoting the accumulation of iron, MDA, and ROS, and ultimately inducing ferroptosis in NSCLC cells. This study elucidates EGCG’s multifaceted mechanisms of action, underscoring the modulation of ferroptosis as a viable therapeutic approach for enhancing NSCLC treatment outcomes.

1 December 2022 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
LWLiming Wang
Liming Wang
TJTian Jiang
Tian Jiang
YYYilin Yang
Yilin Yang
JMJunjie Mao
Junjie Mao
QWQiong Wang
Qiong Wang
JYJun Yin
Jun Yin
Background: Acute lung injury (ALI) is a major cause of mortality and morbidity in the clinic. None of the current pharmacological interventions has achieved a detectable benefit. The renin-angiotensin system (RAS) is a complex humoral system essentially involved in the regulation of ALI. In the RAS family, angiotensin (Ang)-(1–7) was found to provide protection by counteracting the effects of Ang II in various cardiopulmonary disease models. The downstream receptor of Ang-(1–7) is the G protein-coupled receptor (GPCR) Mas. We hypothesize that the Ang-(1–7)-Mas pathway would protect patients from ALI. Methods: To establish a 2-hit ALI model, the mice underwent intratracheal instillation of hydrochloric acid followed by ventilator-induced lung injury (VILI). ALI was evaluated based on lung edema, histology, myeloperoxidase activity, and proinflammatory cytokine production. The effects of the infusion or inhalation of Ang-(1–7) and Mas receptor blocker A779 were examined. The human neutrophils were isolated, and Mas receptor expression was examined. The neutrophil responses to platelet-activating factor (PAF) stimulation were tested by measuring the formation of reactive oxygen species (ROS), neutrophil adhesion, and chemotaxis. Next, in the mouse model, the neutrophils were depleted using an anti-ly6G antibody. Results: The infusion or inhalation of Ang-(1–7) protected mice from ALI as evidenced by decreases in lung edema, the histological lung injury score, myeloperoxidase activity, and proinflammatory cytokine production. Such effects were largely blocked by the Mas receptor blocker A779. Mas receptor expression in the neutrophils was identified at both the messenger ribonucleic acid and protein levels. Ang-(1–7) prevented neutrophil responses to PAF stimulation, including the formation of ROS, neutrophil adhesion, and chemotaxis, while A779 alleviated these effects. The importance of neutrophils in ALI was further confirmed by neutrophil depletion using the anti-ly6G antibody; however, A779 partially reversed the protective role of neutrophil depletion in ALI, indicating the critical role of Ang-(1–7)-Mas signaling in other pulmonary cells. Conclusions: Ang-(1–7)/Mas receptor attenuates the key features of ALI by regulating neutrophil activation. Our study provides new evidence of their role in the pathogenesis of ALI and may lead to the development of a promising therapeutic strategy.

1 December 2022 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
LWLiming Wang
Liming Wang
JYJun Yin
Jun Yin
QWQiong Wang
Qiong Wang
BWBaoqing Wang
Baoqing Wang
YSYuanlin Song
Yuanlin Song
Background: Anti-gamma-aminobutyric-acid B receptor (anti-GABABR) encephalitis is a rare type of encephalitis, with an incidence of only 5% in all autoimmune encephalitis (AE). A third of patients had pathologically confirmed small-cell lung cancer (SCLC). Early identification and treatment of tumors can improve the poor prognosis. Most patients attend hospital for the treatment of neurological disorders and rarely present with any respiratory symptoms, but suffer from an underlying tumor. Thus, early proper diagnosis is very important. In this article, we report a special case of a patient with anti-GABABR encephalitis with delayed SCLC pulmonary behavior, whose diagnosis prosses was tortuous and complicated. Case Description: A 62-year-old man with a history of anti-GABABR encephalitis presented with respiratory symptoms. His chest computed tomography (CT) scan showed significant progression of right superior lobe consolidation. A bronchoscopy was performed with no histopathological result, but the microbiological examination of the bronchial lavage fluid showed Aspergillus niger infection. With antifungal therapy, the patient’s respiratory symptoms were significantly relieved. Given the close relationship between SCLC and anti-GABABR encephalitis, we insisted to clarify the pulmonary lesions. The other three biopsies were performed successively, including lung biopsy, endobronchial ultrasonography (EBUS), and transbronchial needle aspiration (TBNA). SCLC was finally proven by pathology, and the patient received systemic chemotherapy. Conclusions: SCLC is the most common pulmonary neuroendocrine tumor. It secretes onconeural antibodies and is closely associated with paraneoplastic neurologic syndromes (PNSs). Lung tumors, especially SCLC, should be a concern in patients presenting with AE or neurological symptoms, even if they have not any abnormal sign in respiratory system. The early diagnosis and intervention for underlying tumors will improve the clinical outcomes of patients significantly. Thus, the close follow-up is helpful and it is imperative to select and combine the most appropriate examinations for proper diagnosis.

1 January 2021 in Indian Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
JHJie Huang
Jie Huang
RYRonghuan Yu
Ronghuan Yu
QWQiong Wang
Qiong Wang
HCHongqun Chen
Hongqun Chen
BHBin Hu
Bin Hu
BWBaoqing Wang
Baoqing Wang
To explore the application value of metagenomics next generation sequencing of alveolar lavage fluid metagenome in unexplained pulmonary infection. A total of 40 patients with pulmonary infection diagnosed in our hospital from January 2020 to December 2020 were collected. All patients underwent routine blood cell analysis, C-reactive protein, procalcitonin, 1,3-Beta-D glucan test, galactomannan test, sputum smear, sputum culture, blood culture+drug sensitivity, chest computed tomography and other examinations. In addition, sputum, broncho alveolar lavage fluid, blood, pleural effusion and other samples were collected to detect etiology and metagenomics next generation sequencing. Traditional laboratory methods detected pathogens in 60.00 % (24/40) samples, while metagenomics next generation sequencing detected pathogens in 87.50 % (35/40) samples. 12 cases were completely consistent with the traditional method; the results of 5 cases of metagenomics next generation sequencing were partially consistent with those of traditional methods. In these 5 cases, metagenomics next generation sequencing detected potential pathogens which were not detected by traditional methods; In 7 cases, the results of traditional methods were inconsistent with metagenomics next generation sequencing. Chlamydia psittaci was detected in 2 cases by metagenomics next generation sequencing. The results of etiological diagnosis showed that there was no difference in the positive rates of bacterial infection and fungal infection between metagenomics next generation sequencing and traditional methods (p>0.05). The positive rate of metagenomics next generation sequencing virus infection was 84.62 % (11/13), which was significantly higher than that of traditional methods 38.46 % (5/13) (p<0.05). In addition, 7 patients were diagnosed as atypical pathogen infection and the positive rate of metagenomics next generation sequencing was 100 % (7/7), which was significantly higher than that of traditional methods (14.29 %, 1/7) (p<0.05). For difficult and critical patients with infection, using metagenomics next generation sequencing to detect pathogens can improve the early detection rate of pathogens, achieve accurate and individualized treatment, shorten the length of hospital stay and reduce the mortality.

21 October 2026 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
SLShuaihu Li
Shuaihu Li
LZlongfu zhang
longfu zhang
TXTian Xu
Tian Xu
YSYan Shang
Yan Shang
XCXinlei Cai
Xinlei Cai
FLFei Li
Fei Li
Lung cancer remains the leading cause of cancer-related mortality worldwide, highlighting the critical need to identify key oncogenic drivers and develop effective therapeutic strategies. Here, we demonstrate that pre-mRNA processing factor 19 (PRPF19) is significantly upregulated in lung cancer tissues and correlates with poor clinical prognosis. Mechanistically, PRPF19 mediates linear (M1-linked) ubiquitylation of Citron Kinase (CIT), which is essential for CIT midbody localization and successful cytokinesis; PRPF19 knockdown induces cytokinesis failure, cell cycle arrest, and impaired proliferation. In parallel, PRPF19 promotes lysosomal degradation of p65 via linear ubiquitylation, thereby suppressing NF-κB signaling and CXCL10 expression. PRPF19 knockdown stabilizes p65, elevates CXCL10, and enhances CD8 + T cell infiltration and anti-tumor immunity in a CXCL10/CXCR3-dependent manner. Collectively, our findings establish PRPF19 as a dual function regulator governing both cytokinesis and immune evasion in lung cancer, revealing a promising therapeutic target and providing mechanistic basis for novel treatment strategies.